Lexaria Biosciences Corp. (LXRP) is ready for the cannabis boom to come.

The Canadian firm has carved a space for itself in food sciences by developing cutting-edge infusion techniques that could play a major role as legal cannabis continues to gain traction. 

While the company focuses on a number of lipid infusion technologies, its work in cannabis has taken the spotlight. Lexaria is working on high-tech delivery means that it will later sell to companies as an R&D leader and licensing firm. Here's what Lexaria director Chris Bunka told TheStreet at the LD Micro conference in Los Angeles. 

For more from the LD Micro Conference in La:

TheStreet at LD Micro: What CEO Dave Callaway Sees in Small Caps This Year

STK Owner The ONE Group Is Carving Its Own Unique Space in the Dining Experience

SRAX Chief Weighs in as Company Readies for Cryptocurrency Dividend

Snap Interactive's New Blockchain App Could Flip Video Chat on Its Head

Micro Caps Take the Spotlight at LD Micro Conference - Here's What to Expect

Here's How Small Cap Scissor Company Acme United Is Benefitting From Amazon

Here's How Cloud Computing Firm Fusion Is Using M&A to Get Ahead

Biotech Innovator Oncolix Utilizing Novel Treatment to End Women's Cancers

Amazing Energy Isn't Afraid to Take on Big Oil

More from Video

'Canada Is a Sovereign State of Goodness,' Says Jim Cramer

'Canada Is a Sovereign State of Goodness,' Says Jim Cramer

Should You Stay Away From Tech ETFs? Why Jim Cramer Is Sticking to Stocks

Should You Stay Away From Tech ETFs? Why Jim Cramer Is Sticking to Stocks

The Tech Effect: Jim Cramer's Play When the Market's Volatile

The Tech Effect: Jim Cramer's Play When the Market's Volatile

Breaking Up Is So Hard to Do: A Brexit Timeline

Breaking Up Is So Hard to Do: A Brexit Timeline

What to Expect From the Markets in 2019 According to an Abbott Downing Executive

What to Expect From the Markets in 2019 According to an Abbott Downing Executive